Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: Maximum entropy estimates of splice junction strengths

Ataxia‐telangiectasia (A‐T) is an autosomal recessive neurological disorder caused by mutations in the ATM gene. Classical splicing mutations (type I) delete entire exons during pre‐mRNA splicing. In this report, we describe nine examples of nonclassical splicing mutations in 12 A‐T patients and compare cDNA changes to estimates of splice junction strengths based on maximum entropy modeling. These mutations fall into three categories: pseudoexon insertions (type II), single nucleotide changes within the exon (type III), and intronic changes that disrupt the conserved 3′ splice sequence and lead to partial exon deletion (type IV). Four patients with a previously reported type II (pseudoexon) mutation all shared a common founder haplotype. Three patients with apparent missense or silent mutations actually had type III aberrant splicing and partial deletion of an exon. Five patients had type IV mutations that could have been misinterpreted as classical splicing mutations. Instead, their mutations disrupt a splice site and use another AG splice site located nearby within the exon; they lead to partial deletions at the beginning of exons. These nonclassical splicing mutations create frameshifts that result in premature termination codons. Without screening cDNA or using accurate models of splice site strength, the consequences of these genomic mutations cannot be reliably predicted. This may lead to further misinterpretation of genotype–phenotype correlations and may subsequently impact upon gene‐based therapeutic approaches. Hum Mutat 23:67–76, 2004. © 2003 Wiley‐Liss, Inc.

[1]  H. Vinters,et al.  Ataxia‐Telangiectasia: An Interdisciplinary Approach to Pathogenesis , 1991, Medicine.

[2]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[3]  A. Tward,et al.  Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. , 1999, Molecular genetics and metabolism.

[4]  NS22: a highly polymorphic complex microsatellite marker within the ATM gene. , 1999 .

[5]  L L Cavalli-Sforza,et al.  The phylogeography of Y chromosome binary haplotypes and the origins of modern human populations , 2001, Annals of human genetics.

[6]  D. Easton,et al.  ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. , 1998, American journal of human genetics.

[7]  R. Gatti,et al.  A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia. , 1998, Molecular genetics and metabolism.

[8]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[9]  Y. Shiloh,et al.  Genotype-phenotype relationships in ataxia-telangiectasia and variants. , 1998, American journal of human genetics.

[10]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[11]  S. Perlman,et al.  Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. , 1994, Cancer research.

[12]  E. Boder,et al.  Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. , 1958, Pediatrics.

[13]  T. Stankovic,et al.  Mutations associated with variant phenotypes in ataxia-telangiectasia. , 1996, American journal of human genetics.

[14]  Y. Shiloh,et al.  Predominance of null mutations in ataxia-telangiectasia. , 1996, Human molecular genetics.

[15]  T. Dörk,et al.  A new type of mutation causes a splicing defect in ATM , 2002, Nature Genetics.

[16]  R. Gatti,et al.  New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy , 1999, Human mutation.

[17]  Catarina D. Campbell,et al.  Independent mutational events are rare in the ATM gene: Haplotype prescreening enhances mutation detection rate , 2003, Human mutation.

[18]  D. Purdie,et al.  Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer , 2002, Nature Genetics.

[19]  P. Concannon ATM heterozygosity and cancer risk , 2002, Nature Genetics.

[20]  A. Naeim,et al.  Sublocalization of an ataxia-telangiectasia gene distal to D11S384 by ancestral haplotyping in Costa Rican families. , 1995, American journal of human genetics.

[21]  Y. Shiloh,et al.  Genomic Organization of the ATM gene. , 1996, Genomics.

[22]  V. Sheffield,et al.  A high-density microsatellite map of the ataxia-telangiectasia locus , 1995, Human Genetics.

[23]  T. Dörk,et al.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Shiloh,et al.  Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. , 1997, Genome research.

[25]  G. V. Ommen,et al.  The protein truncation test: A review. , 1999 .

[26]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[27]  Catarina D. Campbell,et al.  ATM mutations on distinct SNP and STR haplotypes in ataxia‐telangiectasia patients of differing ethnicities reveal ancestral founder effects , 2003, Human mutation.

[28]  Sara G. Becker-Catania,et al.  Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. , 2002, The Journal of pediatrics.

[29]  J. Sambrook,et al.  Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.

[30]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[31]  Y. Shiloh,et al.  Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. , 1996, American journal of human genetics.

[32]  A. Børresen-Dale,et al.  Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.

[33]  R. W. Davis,et al.  Global analysis of ATM polymorphism reveals significant functional constraint. , 2001, American journal of human genetics.

[34]  K. Flanigan,et al.  Sequence specificity of aminoglycoside‐induced stop codon readthrough: Potential implications for treatment of Duchenne muscular dystrophy , 2000, Annals of neurology.

[35]  F. Collins,et al.  Three dinucleotide repeat polymorphisms at the ataxia-telangiectasia locus. , 1994, Human molecular genetics.

[36]  A. Børresen-Dale,et al.  Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. , 1998, American journal of human genetics.

[37]  Catarina D. Campbell,et al.  Five haplotypes account for fifty‐five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: Seven new mutations , 2004, American journal of medical genetics. Part A.

[38]  T. Dörk,et al.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.

[39]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[40]  Sara G. Becker-Catania,et al.  The pathogenesis of ataxia-telangiectasia , 2001, Clinical reviews in allergy & immunology.

[41]  O. Sanal,et al.  Comprehensive scanning of the ATM gene with DOVAM‐S , 2003, Human mutation.